Literature DB >> 19643987

Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease.

Satoshi Nishiwaki1, Seitaro Terakura, Masafumi Ito, Tatsunori Goto, Aika Seto, Keisuke Watanabe, Mayumi Yanagisawa, Nobuhiko Imahashi, Shokichi Tsukamoto, Makoto Shimba, Yukiyasu Ozawa, Koichi Miyamura.   

Abstract

We retrospectively reviewed 104 biopsy specimens of previously untreated skin acute graft-versus-host disease (GVHD) within 100 days after allogeneic stem cell transplantation, and analyzed the relationship between types of infiltrating cells and clinical outcomes. Counting the total number of CD8(+) T cells, CD163(+) macrophages, and CD1a(+) dendritic cells in 4 fields under original magnification x200, the infiltration of more than 200 cells of CD163(+) macrophages (many macrophages [MM]) was the only significant predictor for refractory GHVD (odds ratio, 3.79; 95% confidence interval, 1.22-11.8; P = .02). In 46 patients given steroid treatments, MM was the only significant predictor for refractory acute GVHD (odds ratio, 5.05; 95% confidence interval, 1.19-21.3; P = .03). Overall survival of patients with MM was significantly lower than that of those with an infiltration of less than 200 cells of CD163(+) macrophages. Macrophage infiltration of skin lesions could be a significant predictive factor for refractory GVHD and a poor prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19643987     DOI: 10.1182/blood-2009-03-209635

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Histiocytic sarcoma with two immunohistopathologically distinct populations.

Authors:  Kanako Wakahashi; Manabu Shimoyama; Yoshio Katayama; Kentaro Minagawa; Kenji Yoshida; Ryohei Sasaki; Shunji Nakayama; Hiroshi Yokozaki; Emmy Yanagita; Tomoo Itoh; Yoshitake Hayashi; Toshimitsu Matsui
Journal:  Int J Hematol       Date:  2010-10-06       Impact factor: 2.490

2.  CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.

Authors:  Kylie A Alexander; Ryan Flynn; Katie E Lineburg; Rachel D Kuns; Bianca E Teal; Stuart D Olver; Mary Lor; Neil C Raffelt; Motoko Koyama; Lucie Leveque; Laetitia Le Texier; Michelle Melino; Kate A Markey; Antiopi Varelias; Christian Engwerda; Jonathan S Serody; Baptiste Janela; Florent Ginhoux; Andrew D Clouston; Bruce R Blazar; Geoffrey R Hill; Kelli P A MacDonald
Journal:  J Clin Invest       Date:  2014-08-26       Impact factor: 14.808

3.  Cutaneous macrophage infiltration in acute GvHD.

Authors:  S Terakura; P J Martin; H M Shulman; B E Storer
Journal:  Bone Marrow Transplant       Date:  2015-05-11       Impact factor: 5.483

4.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

Review 5.  Acute graft-versus-host disease: a bench-to-bedside update.

Authors:  Shernan G Holtan; Marcelo Pasquini; Daniel J Weisdorf
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

6.  Organ siderosis and hemophagocytosis during acute graft-versus-host disease.

Authors:  Axel Nogai; Yu Shi; Daniel Pérez-Hernandez; Steffen Cordes; Jörg Mengwasser; Sarah Mertlitz; Katarina Riesner; Martina Kalupa; Jan-Hendrik Erdmann; Reinhard Ziebig; Gunnar Dittmar; Olaf Penack
Journal:  Haematologica       Date:  2016-05-19       Impact factor: 9.941

7.  STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

Authors:  Evelyn C Nieves; Tomomi Toubai; Daniel C Peltier; Katherine Oravecz-Wilson; Chen Liu; Hiroya Tamaki; Yaping Sun; Pavan Reddy
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-08       Impact factor: 5.742

8.  Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation.

Authors:  N Kawashima; S Terakura; S Nishiwaki; D Koyama; Y Ozawa; M Ito; K Miyamura
Journal:  Bone Marrow Transplant       Date:  2017-04-03       Impact factor: 5.483

9.  Dynamics of M1 macrophages in oral mucosal lesions during the development of acute graft-versus-host disease in rats.

Authors:  K Seno; M Yasunaga; H Kajiya; K Izaki-Hagio; H Morita; M Yoneda; T Hirofuji; J Ohno
Journal:  Clin Exp Immunol       Date:  2017-09-28       Impact factor: 4.330

10.  The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment.

Authors:  Qiao Cheng; Shoubao Ma; Dandan Lin; Yu Mei; Huanle Gong; Lei Lei; Yuanyuan Chen; Ye Zhao; Bo Hu; Yan Wu; Xiao Yu; Lixiang Zhao; Haiyan Liu
Journal:  Cell Mol Immunol       Date:  2014-08-04       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.